GlassScriptPhysician profile
Meagan Ethridge
NPI 1023817269
$2,143.16
in general payments reported to CMS, 2019-2025
37 companies · $2,143 in 2025
The $2,143 reported for 2025 was more than what 95% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $2,143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,964 · Education: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,964.16 |
| Education | $179.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $284.85 | 2025 | Rybrevant, Darzalex, Talvey |
| Novartis Pharmaceuticals Corporation | $166.88 | 2025 | |
| Genzyme Corporation | $145.85 | 2025 | |
| Daiichi Sankyo INC. | $140.72 | 2025 | Injectafer, Enhertu |
| Incyte Corporation | $97.25 | 2025 | Jakafi, Monjuvi, Pemazyre |
| Gilead Sciences, INC. | $95.47 | 2025 | Trodelvy |
| E.R. Squibb & Sons, L.L.C. | $79.81 | 2025 | Opdivo |
| Merck Sharp & Dohme LLC | $74.31 | 2025 | Keytruda, Lynparza |
| Sobi, INC | $70.09 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $69.72 | 2025 | Imfinzi, Lynparza |
| Abbvie INC. | $68.78 | 2025 | |
| Servier Pharmaceuticals LLC | $65.51 | 2025 | |
| Tersera Therapeutics LLC | $64.52 | 2025 | Xermelo, Zoladex |
| Bayer Healthcare Pharmaceuticals INC. | $63.98 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $52.05 | 2025 | Fruzaqla, Iclusig |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meagan Ethridge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.